Wu Xi Zhen - Net Worth and Insider Trading
Wu Xi Zhen Net Worth
The estimated net worth of Wu Xi Zhen is at least $10 Million dollars as of 2024-06-23. Wu Xi Zhen is the Director of Henan Lingrui Pharmaceutical Co Ltd and owns about 415,560 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) stock worth over $10 Million. Details can be seen in Wu Xi Zhen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wu Xi Zhen has not made any transactions after 2024-05-24 and currently still holds the listed stock(s).
Transaction Summary of Wu Xi Zhen
Wu Xi Zhen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Xi Zhen owns 1 companies in total, including Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) .
Click here to see the complete history of Wu Xi Zhen’s form 4 insider trades.
Insider Ownership Summary of Wu Xi Zhen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2024-05-24 | Director |
Wu Xi Zhen Latest Holdings Summary
Wu Xi Zhen currently owns a total of 1 stock. Wu Xi Zhen owns 415,560 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) as of May 24, 2024, with a value of $10 Million.
Latest Holdings of Wu Xi Zhen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2024-05-24 | 415,560 | 24.30 | 10,098,108 |
Holding Weightings of Wu Xi Zhen
Wu Xi Zhen Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Xi Zhen has made a total of 9 transactions in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Henan Lingrui Pharmaceutical Co Ltd is the sale of 138,500 shares on May 24, 2024, which brought Wu Xi Zhen around $3 Million.
Insider Trading History of Wu Xi Zhen
- 1
Wu Xi Zhen Trading Performance
GuruFocus tracks the stock performance after each of Wu Xi Zhen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Xi Zhen is -1%. GuruFocus also compares Wu Xi Zhen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Xi Zhen within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Xi Zhen's insider trading performs compared to the benchmark.
Performance of Wu Xi Zhen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.12 | | | | | |
| Relative Return to S&P 500(%) | -8.49 | | | | | |
Wu Xi Zhen Ownership Network
Wu Xi Zhen Owned Company Details
What does Henan Lingrui Pharmaceutical Co Ltd do?
Who are the key executives at Henan Lingrui Pharmaceutical Co Ltd?
Wu Xi Zhen is the Director of Henan Lingrui Pharmaceutical Co Ltd. Other key executives at Henan Lingrui Pharmaceutical Co Ltd include Supervisors Li Jin , senior management Ye Qiang , and Directors & senior managers Chen Yan .
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) Insider Trades Summary
Over the past 18 months, Wu Xi Zhen made 3 insider transaction in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) with a net sale of 298,500. Other recent insider transactions involving Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) include a net sale of 93,600 shares made by Li Jin ,
In summary, during the past 3 months, insiders sold 186,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) in total and bought 0 shares, with a net sale of 186,100 shares. During the past 18 months, 392,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) were sold and 0 shares were bought by its insiders, resulting in a net sale of 392,100 shares.
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285)'s detailed insider trading history can be found in Insider Trading Tracker table.
Henan Lingrui Pharmaceutical Co Ltd Insider Transactions
Wu Xi Zhen Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Xi Zhen. Currently GuruFocus does not have mailing address information for Wu Xi Zhen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
